![Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Group Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Group](https://www.emg-health.com/wp-content/uploads/2018/04/Patient-Centricity-in-IBD-Treatment-An-Interview-with-Dr-Corey-Siegel-at-the-13th-Congress-of-ECCO.jpg)
Patient Centricity in IBD Treatment: An Interview with Dr Corey Siegel at the 13th Congress of ECCO - European Medical Group
![Entering a New Era of Patient-Reported Outcomes in Inflammatory Bowel Disease: Past, Present, and Future - European Medical Journal Entering a New Era of Patient-Reported Outcomes in Inflammatory Bowel Disease: Past, Present, and Future - European Medical Journal](https://emj.emg-health.com/wp-content/uploads/sites/2/2018/08/EMJ-Gastroenterol.-2018-Suppl-2-Takeda.jpg)
Entering a New Era of Patient-Reported Outcomes in Inflammatory Bowel Disease: Past, Present, and Future - European Medical Journal
![European Crohn's and Colitis Organisation returns to Vienna in 2018 - KONGRES – Europe Events and Meetings Industry Magazine European Crohn's and Colitis Organisation returns to Vienna in 2018 - KONGRES – Europe Events and Meetings Industry Magazine](https://kongres-magazine.eu/wp-content/uploads/2017/02/IMG_4737-800x600.jpg)
European Crohn's and Colitis Organisation returns to Vienna in 2018 - KONGRES – Europe Events and Meetings Industry Magazine
![British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut](https://gut.bmj.com/content/gutjnl/68/Suppl_3/s1/F2.large.jpg)
British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults | Gut
![Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease | SpringerLink Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10620-019-06036-0/MediaObjects/10620_2019_6036_Fig1_HTML.png)
Systematic Review: Non-medical Switching of Infliximab to CT-P13 in Inflammatory Bowel Disease | SpringerLink
![PDF) ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications PDF) ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications](https://i1.rgstatic.net/publication/339011349_ECCO-ESGAR_guideline_for_diagnostic_assessment_in_IBD_part_1_initial_diagnosis_monitoring_of_known_IBD_detection_of_complications/links/5f8990c792851c14bccc3896/largepreview.png)
PDF) ECCO-ESGAR guideline for diagnostic assessment in IBD part 1: initial diagnosis, monitoring of known IBD, detection of complications
![Frontiers | Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment | Bioengineering and Biotechnology Frontiers | Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment | Bioengineering and Biotechnology](https://www.frontiersin.org/files/Articles/675194/fbioe-09-675194-HTML/image_m/fbioe-09-675194-g001.jpg)
Frontiers | Oral Delivery of Biologics in Inflammatory Bowel Disease Treatment | Bioengineering and Biotechnology
![Endoscopic resection of colon dysplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis - Gastrointestinal Endoscopy Endoscopic resection of colon dysplasia in patients with inflammatory bowel disease: a systematic review and meta-analysis - Gastrointestinal Endoscopy](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/1f9c8e65-9d98-40fc-825a-8a3d6c638545/fx2_lrg.jpg)